Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.
Antimicrob Agents Chemother. 2011 Jun;55(6):2585-9. doi: 10.1128/AAC.00891-10. Epub 2011 Mar 21.
An understanding of the impact of antibiotics on the intestinal reservoir of KPC carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) is important to prevent its emergence. We used a mouse model to examine the effect of antibiotic treatment on the establishment and elimination of intestinal colonization with KPC-Kp. Mice (10 per group) received subcutaneous antibiotics daily for 8 days. On day 3 of treatment, 10(3) CFU of KPC-Kp was given orogastrically, and concentrations of KPC-Kp in stool were monitored. Additional experiments assessed the effects of antibiotic treatment on concentrations of total anaerobes and Bacteroides spp. in stool and the efficacy of orogastric gentamicin and polymyxin E in suppressing KPC-Kp colonization. Of four antibiotics with minimal activity against the KPC-Kp test strain (MIC ≥ 16 μg/ml), those that suppressed total anaerobes and bacteroides (i.e., clindamycin and piperacillin-tazobactam) promoted colonization by KPC-Kp (P < 0.001), whereas agents that did not suppress total anaerobes or bacteroides (i.e., ciprofloxacin and cefepime) did not (P = 0.35). Of two agents with moderate activity against the KPC-Kp test strain, ertapenem (MIC, 4 μg/ml) did not promote colonization by KPC-Kp, whereas tigecycline (MIC, 3 μg/ml) did (P < 0.001), despite not reducing levels of total anaerobes or bacteroides. Orogastric treatment with gentamicin and polymyxin E suppressed KPC-Kp to undetectable levels in the majority of mice. These data suggest that antibiotics that disturb the intestinal anaerobic microflora and lack significant activity against KPC-Kp promote colonization by this organism. The administration of nonabsorbed oral antibiotics may be an effective strategy to suppress colonization with KPC-Kp.
了解抗生素对产 KPC 碳青霉烯酶肺炎克雷伯菌 (KPC-Kp) 肠道储库的影响对于预防其出现很重要。我们使用小鼠模型研究了抗生素治疗对肠道定植 KPC-Kp 的建立和消除的影响。每组 10 只小鼠每天接受皮下抗生素治疗 8 天。在治疗第 3 天,经口给予 10(3) CFU 的 KPC-Kp,并监测粪便中 KPC-Kp 的浓度。其他实验评估了抗生素治疗对粪便中总厌氧菌和拟杆菌属浓度的影响,以及经口给予庆大霉素和多粘菌素 E 抑制 KPC-Kp 定植的效果。在对 KPC-Kp 测试菌株活性最小的四种抗生素(MIC≥16μg/ml)中,抑制总厌氧菌和拟杆菌的药物(即克林霉素和哌拉西林-他唑巴坦)促进了 KPC-Kp 的定植(P<0.001),而不抑制总厌氧菌或拟杆菌的药物(即环丙沙星和头孢吡肟)则没有(P=0.35)。在对 KPC-Kp 测试菌株具有中度活性的两种药物中,厄他培南(MIC,4μg/ml)未促进 KPC-Kp 的定植,而替加环素(MIC,3μg/ml)则促进了 KPC-Kp 的定植(P<0.001),尽管它没有降低总厌氧菌或拟杆菌的水平。经口给予庆大霉素和多粘菌素 E 可使大多数小鼠粪便中的 KPC-Kp 抑制到无法检测的水平。这些数据表明,扰乱肠道厌氧菌群且对 KPC-Kp 缺乏显著活性的抗生素可促进该生物体的定植。给予非吸收性口服抗生素可能是抑制 KPC-Kp 定植的有效策略。